Concomitant systemic or local antibiotics

Concomitant systemic or local antibiotics refers to the simultaneous administration of antimicrobial agents alongside another primary treatment or within the context of a clinical study protocol (NIH, 2023). This term does not describe a single biological target such as a receptor or enzyme, but rather a category of pharmacological intervention used to treat or prevent bacterial infections (StatPearls, 2024). Systemic antibiotics are distributed throughout the body via the circulatory system, whereas local antibiotics are applied directly to a specific site, such as the skin or a surgical wound (Mayo Clinic, 2023). In clinical research, the use of concomitant antibiotics is often a controlled variable or an exclusion criterion to prevent confounding results in trials evaluating new anti-infectives or anti-inflammatory drugs (FDA, 2022). The specific biological impact depends on the class of antibiotic used, targeting various bacterial structures or processes to achieve bacteriostatic or bactericidal effects (WHO, 2023). These agents are critical for managing secondary infections but require careful monitoring for potential drug-drug interactions and the development of antimicrobial resistance (CDC, 2023).

Other names

Concomitant antibiotic therapyConcurrent antibioticsSystemic or topical antibioticsConcomitant antimicrobial therapy

Antibiotics function by inhibiting essential bacterial processes including cell wall synthesis, protein synthesis, and nucleic acid replication (StatPearls, 2024).